Allergy and Immunology · Chattanooga, TN
NPI
1487623989
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6734 Lee Hwy
Chattanooga, TN, 37421
Phone (423) 899-0431
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
62,039 services
Medicare patients, 2024
549
Average age 72
Drug cost, 2024
$2.2M
5,748 prescriptions
Company payments, 2025
$4,939
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Todd A Levin was code J2356 (injection, tezepelumab-ekko, 1 mg), 26,046 times for 16 patients. In total Todd A Levin billed 62,039 services in 35 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 26,046 | 16 | $14.13 | $368K |
| J2357 Injection, omalizumab, 5 mg | Office | 7,925 | 13 | $29.42 | $233K |
| 95165 Treatment - Miscellaneous | Office | 7,728 | 316 | $9.85 | $76K |
| 95117 Treatment - Miscellaneous | Office | 7,287 | 346 | $7.85 | $57K |
| 95004 Test - Miscellaneous | Office | 5,446 | 84 | $2.38 | $13K |
| J0517 Injection, benralizumab, 1 mg | Office | 3,663 | 23 | $130.84 | $479K |
| 95024 Test - Miscellaneous | Office | 1,355 | 75 | $5.37 | $7,271 |
| 96372 Injection Administration | Office | 601 | 56 | $9.61 | $5,774 |
| 99214 Office E&M - Established | Office | 274 | 212 | $86.05 | $24K |
| 95115 Treatment - Miscellaneous | Office | 192 | 17 | $5.59 | $1,074 |
| 95012 Pulmonary | Office | 191 | 160 | $12.88 | $2,460 |
| 94010 Pulmonary Function Testing | Office | 148 | 121 | $18.43 | $2,728 |
| 99204 Office E&M - New | Office | 104 | 104 | $106.34 | $11K |
| 94060 Pulmonary Function Testing | Office | 48 | 48 | $26.84 | $1,288 |
| G0008 Administration of influenza virus vaccine | Office | 42 | 40 | $29.40 | $1,235 |
By year: 2022 $841K for 34,054 services; 2023 $1.1M for 41,667 services; 2024 $1.3M for 62,039 services.
Medicare prescription drug claims, 2024
In 2024, the drug Todd A Levin prescribed most often to Medicare patients was Montelukast Sodium, with 726 prescriptions and refills. In total Todd A Levin wrote 5,748 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 726 | 1,556 | 256 | $7,766 |
| Fluticasone Propionate Generic | 545 | 1,085 | 251 | $9,197 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 535 | 665 | 268 | $15K |
| Levocetirizine Dihydrochloride Generic | 534 | 1,058 | 181 | $6,908 |
| Azelastine Hcl Generic | 520 | 1,035 | 276 | $22K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 389 | 518 | 110 | $324K |
| Famotidine Generic | 377 | 738 | 141 | $5,645 |
| Ipratropium Bromide Generic | 199 | 300 | 78 | $8,954 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 138 | 161 | 37 | $99K |
| Epinephrine Generic | 125 | 132 | 103 | $26K |
| Symbicort Budesonide/Formoterol Fumarate | 116 | 154 | 44 | $33K |
| Xolair Omalizumab | 109 | 109 | 13 | $476K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 79 | 109 | 28 | $14K |
| Azithromycin Generic | 76 | 85 | 20 | $1,305 |
| Breo Ellipta Fluticasone/Vilanterol | 76 | 130 | 32 | $51K |
Brand drugs: 1,798 claims; generic drugs: 3,950 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Todd A Levin $4,939 ($4,939 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $2,514.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 16 | $2,514 |
| Regeneron Healthcare Solutions, Inc. REGN | 18 | $467 |
| Genzyme Corporation SNY | 14 | $342 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 9 | $239 |
| Pfizer Inc. PFE | 9 | $215 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $142 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $142 |
| Genentech USA, Inc. ROG.SW | 5 | $114 |
| Grifols USA, LLC | 5 | $114 |
| Amgen Inc. AMGN | 4 | $96.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.